Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BY 4.0Frontiers in Endocrinology

Long-chain acyl-CoA synthetases in female reproductive diseases: isoform-specific regulation of lipid metabolism, ferroptosis, and inflammatory signaling

4 affiliations
  1. 1Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dalian Medical University
  2. 2Advanced Institute for Medical Sciences, Dalian Medical University
  3. 3Department of Otorhinolaryngology, the Second Hospital of Dalian Medical University
  4. 4School of Basic Medical Sciences, Dalian University of Technology

Abstract

Female reproductive diseases (FRDs) substantially affect women’s health and fertility, with lipid metabolic reprogramming emerging as a shared pathological feature. Long-chain acyl-CoA synthetases (ACSLs) activate long-chain fatty acids and direct lipid flux toward β-oxidation, lipid synthesis, and phospholipid remodeling, thereby influencing oxidative stress, ferroptosis, and inflammatory signaling. Unlike previous reviews centered on broad ACSL biology, selected isoforms, or pathway-based ferroptosis mechanisms, this review adopts a disease-spanning, isoform-specific framework. We compare ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6 across cervical, ovarian, and endometrial cancers, polycystic ovary syndrome, endometriosis, and preeclampsia. By integrating isoform-specific substrate preference, subcellular localization, and lipid-channeling functions, we examine how individual ACSLs differentially regulate fatty acid oxidation, lipid synthesis and phospholipid remodeling, ferroptosis sensitivity, and inflammatory signaling across reproductive disease contexts. We further distinguish disease-specific experimental evidence from bioinformatic associations and mechanistic extrapolations from other disease models. Current evidence most consistently supports a disease-relevant role for ACSL4 in ferroptosis regulation, whereas ACSL1, ACSL3, ACSL5, and ACSL6 show greater context dependence. This integrated framework identifies shared metabolic mechanisms, disease-specific differences, and priorities for cell-resolved validation and future isoform-selective therapeutic development.

Related

  1. The ferroptosis inhibitor NUPR1 coordinates the mitochondrial response to oxidative stress and cell metabolism during COPD pathogenesis in the lung
    Jessica Nouws, Saul S. Siller, Tao Yang +7
    American journal of physiology. Lung cellular and molecular physiologyPeer-reviewedCC BYFull text2 citedOncologyPMC
  2. Identification and validation of prognostic characteristics of survival risk marker genes associated with ferroptosis and iron metabolism in breast cancer
    Mengxi Li, Baoqing Zhao, Zhenwang Zhang
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicasPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  3. Lipid Metabolism and Ferroptosis in Cancer: Regulatory Mechanisms, Alternative Splicing, and Therapeutic Implications
    Lucia Maria Procopciuc, Adriana Corina Hangan, Roxana Liana Lucaciu
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  4. Pharmacological regulation of chondrocyte ferroptosis by plant-derived metabolites in osteoarthritis: from molecular mechanisms to targeted nanodelivery
    Tianci Guo, Qi Liu, Jida Wang +4
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCCrossref
  5. Dopamine Metabolism as a Chemically Constrained Network: Structural Regulation, Redox Liability and Dopaminergic Vulnerability in Parkinson’s Disease
    Emmanuel Ortega-Robles, Magdalena Guerra-Crespo, Oscar Arias-Carrión
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{jin2026longchain,
  title = {{Long-chain acyl-CoA synthetases in female reproductive diseases: isoform-specific regulation of lipid metabolism, ferroptosis, and inflammatory signaling}},
  author = {Shanyuan Jin and Lin Guo and Zishuo Wu and Zirong Wang and Runyuan Liu and Ying Kong and Hongshuo Zhang},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  month = oct,
  doi = {10.3389/fendo.2026.1967984},
  url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1967984/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Long-chain acyl-CoA synthetases in female reproductive diseases: isoform-specific regulation of lipid metabolism, ferroptosis, and inflammatory signaling
AU  - Shanyuan Jin
AU  - Lin Guo
AU  - Zishuo Wu
AU  - Zirong Wang
AU  - Runyuan Liu
AU  - Ying Kong
AU  - Hongshuo Zhang
PY  - 2026
DA  - 2026/10/28
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.1967984
UR  - https://www.frontiersin.org/articles/10.3389/fendo.2026.1967984/full
AB  - Female reproductive diseases (FRDs) substantially affect women’s health and fertility, with lipid metabolic reprogramming emerging as a shared pathological feature. Long-chain acyl-CoA synthetases (ACSLs) activate long-chain fatty acids and direct lipid flux toward β-oxidation, lipid synthesis, and phospholipid remodeling, thereby influencing oxidative stress, ferroptosis, and inflammatory signaling. Unlike previous reviews centered on broad ACSL biology, selected isoforms, or pathway-based ferroptosis mechanisms, this review adopts a disease-spanning, isoform-specific framework. We compare ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6 across cervical, ovarian, and endometrial cancers, polycystic ovary syndrome, endometriosis, and preeclampsia. By integrating isoform-specific substrate preference, subcellular localization, and lipid-channeling functions, we examine how individual ACSLs differentially regulate fatty acid oxidation, lipid synthesis and phospholipid remodeling, ferroptosis sensitivity, and inflammatory signaling across reproductive disease contexts. We further distinguish disease-specific experimental evidence from bioinformatic associations and mechanistic extrapolations from other disease models. Current evidence most consistently supports a disease-relevant role for ACSL4 in ferroptosis regulation, whereas ACSL1, ACSL3, ACSL5, and ACSL6 show greater context dependence. This integrated framework identifies shared metabolic mechanisms, disease-specific differences, and priorities for cell-resolved validation and future isoform-selective therapeutic development.
SN  - 1664-2392
ER  -